vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Globalstar, Inc. (GSAT). Click either name above to swap in a different company.
Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $72.0M, roughly 1.1× Globalstar, Inc.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -16.1%, a 6.5% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs -16.8%). Over the past eight quarters, Globalstar, Inc.'s revenue compounded faster (12.9% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
BIOX vs GSAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $72.0M |
| Net Profit | $-7.4M | $-11.6M |
| Gross Margin | 46.8% | — |
| Operating Margin | 9.3% | -0.5% |
| Net Margin | -9.6% | -16.1% |
| Revenue YoY | -16.8% | 17.6% |
| Net Profit YoY | -20.2% | 76.9% |
| EPS (diluted) | $-0.12 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $72.0M | ||
| Q3 25 | $77.6M | $73.8M | ||
| Q2 25 | — | $67.1M | ||
| Q1 25 | $60.6M | $60.0M | ||
| Q4 24 | $98.8M | $61.2M | ||
| Q3 24 | $93.3M | $72.3M | ||
| Q2 24 | — | $60.4M | ||
| Q1 24 | $84.0M | $56.5M |
| Q4 25 | — | $-11.6M | ||
| Q3 25 | $-7.4M | $1.1M | ||
| Q2 25 | — | $19.2M | ||
| Q1 25 | $-1.6M | $-17.3M | ||
| Q4 24 | $605.2K | $-50.2M | ||
| Q3 24 | $-6.2M | $9.9M | ||
| Q2 24 | — | $-9.7M | ||
| Q1 24 | $9.8M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — |
| Q4 25 | — | -0.5% | ||
| Q3 25 | 9.3% | 13.8% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | 1.5% | -14.2% | ||
| Q4 24 | 14.5% | -6.9% | ||
| Q3 24 | 2.5% | 13.0% | ||
| Q2 24 | — | -2.4% | ||
| Q1 24 | 15.7% | -8.3% |
| Q4 25 | — | -16.1% | ||
| Q3 25 | -9.6% | 1.5% | ||
| Q2 25 | — | 28.6% | ||
| Q1 25 | -2.6% | -28.9% | ||
| Q4 24 | 0.6% | -82.1% | ||
| Q3 24 | -6.6% | 13.7% | ||
| Q2 24 | — | -16.0% | ||
| Q1 24 | 11.6% | -23.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.12 | $-0.01 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | $-0.02 | $-0.16 | ||
| Q4 24 | $0.00 | $-0.57 | ||
| Q3 24 | $-0.10 | $0.00 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | $0.14 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $447.5M |
| Total DebtLower is stronger | — | $483.8M |
| Stockholders' EquityBook value | $288.3M | $355.7M |
| Total Assets | $734.9M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.36× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $447.5M | ||
| Q3 25 | $15.5M | $346.3M | ||
| Q2 25 | — | $308.2M | ||
| Q1 25 | $38.5M | $241.4M | ||
| Q4 24 | $29.2M | $391.2M | ||
| Q3 24 | $32.3M | $51.9M | ||
| Q2 24 | — | $64.3M | ||
| Q1 24 | $16.4M | $59.3M |
| Q4 25 | — | $483.8M | ||
| Q3 25 | — | $508.6M | ||
| Q2 25 | — | $491.5M | ||
| Q1 25 | — | $502.7M | ||
| Q4 24 | — | $511.4M | ||
| Q3 24 | — | $394.4M | ||
| Q2 24 | — | $393.1M | ||
| Q1 24 | — | $398.7M |
| Q4 25 | — | $355.7M | ||
| Q3 25 | $288.3M | $364.8M | ||
| Q2 25 | — | $360.9M | ||
| Q1 25 | $345.0M | $344.3M | ||
| Q4 24 | $346.3M | $358.9M | ||
| Q3 24 | $346.0M | $394.1M | ||
| Q2 24 | — | $383.0M | ||
| Q1 24 | $348.5M | $377.1M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | $734.9M | $2.2B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | $798.2M | $1.7B | ||
| Q4 24 | $835.2M | $1.7B | ||
| Q3 24 | $827.3M | $917.6M | ||
| Q2 24 | — | $926.2M | ||
| Q1 24 | $836.1M | $917.0M |
| Q4 25 | — | 1.36× | ||
| Q3 25 | — | 1.39× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.46× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | 1.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $175.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $175.9M | ||
| Q3 25 | $14.4M | $236.0M | ||
| Q2 25 | — | $157.9M | ||
| Q1 25 | $23.3M | $51.9M | ||
| Q4 24 | $-5.4M | $340.7M | ||
| Q3 24 | $5.2M | $32.0M | ||
| Q2 24 | — | $36.7M | ||
| Q1 24 | $-17.4M | $29.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 216.53× | ||
| Q2 25 | — | 8.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | 3.23× | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
